Valeant Pharmaceuticals International Inc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc.
SHPGShire PLC Sponsored ADR
PRGOPerrigo Co. Plc
MNKMallinckrodt Plc
SAGESAGE Therapeutics, Inc.
JAZZJazz Pharmaceuticals Plc
PTLAPortola Pharmaceuticals, Inc.
UTHRUnited Therapeutics Corporation
GWPHGW Pharmaceuticals PLC Sponsored ADR
MDCOMedicines Company
ENDPEndo International Plc
ICPTIntercept Pharmaceuticals, Inc.
SUPNSupernus Pharmaceuticals, Inc.
PCRXPacira Pharmaceuticals, Inc.

Company Profile

Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment refers to the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.